U.S. markets close in 4 hours 44 minutes

  • S&P 500

    3,914.76
    +3.02 (+0.08%)
     

  • Dow 30

    31,514.35
    +13.67 (+0.04%)
     

  • Nasdaq

    11,581.73
    -25.89 (-0.22%)
     

  • Russell 2000

    1,777.75
    +12.02 (+0.68%)
     

  • Crude Oil

    109.30
    +1.68 (+1.56%)
     

  • Gold

    1,823.90
    -6.40 (-0.35%)
     

  • Silver

    21.23
    +0.10 (+0.50%)
     

  • EUR/USD

    1.0610
    +0.0052 (+0.49%)
     

  • 10-Yr Bond

    3.1790
    +0.0540 (+1.73%)
     

  • GBP/USD

    1.2307
    +0.0037 (+0.31%)
     

  • USD/JPY

    135.0900
    -0.0800 (-0.06%)
     

  • BTC-USD

    20,741.88
    -541.96 (-2.55%)
     

  • CMC Crypto 200

    451.57
    -10.23 (-2.21%)
     

  • FTSE 100

    7,265.14
    +56.33 (+0.78%)
     

  • Nikkei 225

    26,871.27
    +379.30 (+1.43%)
     

NZ central bank removes dividend restrictions on banks

June 2 (Reuters) - The Reserve Bank of New Zealand said on Thursday it will allow registered trading banks to resume paying dividends, lifting the complete restriction it had placed at the height of the COVID-19 pandemic.

The central bank also remained cautious of the global economic headwinds and urged banks to take into account the higher capital requirements to ensure their financial health. (Reporting by Harshita Swaminathan in Bengaluru; Editing by Arun Koyyur)

Recommended Stories

  • Why Axsome Therapeutics Stock Is On Fire Today

    Axsome Therapeutics (NASDAQ: AXSM), a newly minted commercial-stage biopharma, is set for a strong session today. Ahead of the opening bell this morning, Axsome released an 8-K filing with the Securities and Exchange Commission revealing that it has received the proposed labeling from the Food and Drug Administration (FDA) for the experimental major depressive disorder drug known as AXS-05. The FDA reportedly sent Axsome this long-awaited regulatory update last Friday.

  • 3 Reasons to Buy Novavax and 1 to Sell

    Novavax (NASDAQ: NVAX) is a pandemic stock. Now it's down to $50, and the company's market cap is under $4 billion. Here are three arguments for buying Novavax stock and one reason for why you might want to avoid these shares.

  • Robert Kiyosaki says that hot inflation will 'wipe out 50% of the US population' — here's what he means by that and how to protect yourself

    'Rich Dad Poor Dad' is more bearish than ever.

  • Should You Consider Investing in NIO?

    Horos Asset Management, an investment management firm, published its first-quarter 2022 investor letter – a copy of which can be downloaded here. Since the inception of Horos (May 21, 2018), Horos Value Internacional has returned 22.3%, below the 55.2% gain of its benchmark, while Horos Value Iberia has returned 8.1%, outperforming the 0.5% return of […]

  • Plug Power bought a company for $123 million. That investment is about to become its biggest business

    "One of the reasons the sales funnel for electrolyzers continues to grow is because of the atrocities that are happening in Ukraine," says Plug Power chief executive Marsh.

  • Axsome Therapeutics Stock Soars on Proposed FDA Labeling for Depression Drug

    Axsome announces it has received proposed labeling from the FDA related to its new drug application for AXS-05.

  • 11 Best Undervalued Stocks to Buy Now

    In this article, we will look at 11 best undervalued stocks to buy now. If you want to explore similar stocks, you can also read 5 Best Undervalued Stocks to Buy Now. Value investing has long been an investors’ go-to strategy to come atop the broad market and pocket huge profits for themselves and their […]

  • Trump-Tied SPAC Tumbles After Disclosing Grand Jury Subpoena

    (Bloomberg) -- Digital World Acquisition Corp., the special purpose acquisition company merging with Trump Media & Technology Group, tumbled after disclosing that a federal grand jury in the Southern District of New York issued subpoenas to the company and members of its board of directors. Most Read from BloombergRussia Defaults on Foreign Debt for First Time Since 1918Hyundai Quietly Climbs the EV Sales Charts and Elon Musk NoticesRep. Mary Miller Calls Roe Decision ‘Victory for White Life’Rus

  • Should Investors Be Worried After Palantir's Q1 Earnings?

    Palantir's first-quarter results got a mixed review from investors, but the underlying fundamentals offer some encouragement.

  • Jim Cramer Recommends These 10 Stocks for Recession

    In this article, we discuss the 10 stocks that Jim Cramer recommends for recession. If you want to read about some more stocks that Jim Cramer recommends for recession, go directly to Jim Cramer Recommends These 5 Stocks for Recession. Recession fears have steadily been gathering pace at the stock market over the past few […]

  • Bank of America Could Lose $44 Billion in a Severe Recession. Should Investors Be Worried?

    The Federal Reserve recently released the results of its annual stress testing, in which it puts the largest banks in the country through a set of hypothetical severe economic conditions akin to a severe recession. This year, the Fed was not messing around. Between the fourth quarter of 2021 and through the first quarter of 2024, the Fed's hypothetical scenario included unemployment rising above 10%, commercial real estate prices dropping 40%, and stock prices dropping 55%.

  • Tesla Has a New Rival on the Rise

    The maker of premium and high-end electric vehicles remains the market leader in electric vehicles but sees a threatening rival.

  • 3 Stocks That Could Help Set You Up for Life

    A strange thing is happening on Wall Street: After months of falling stock prices and rising pessimism, some respected analysts are predicting that technology stocks have bottomed. Analysts expect it to generate an earnings per share of $3.44 this year and $4.53 next year.

  • Bristol-Myers Squibb Company (NYSE:BMY) Stock Goes Ex-Dividend In Just Two Days

    Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Bristol-Myers...

  • ‘A cold dark place’ — Michael Burry thinks the market has plenty of room to plunge. But he finally sees value in these 4 stocks

    Burry’s not bullish. But he’s beginning to nibble.

  • Got $5,000? These Are 2 of the Best Growth Stocks to Buy Right Now.

    A market sell-off can be a hard reminder to investors in growth stocks about how volatile such stocks can be. To be sure, investing in growth stocks can help you earn a fortune, but the journey is far from easy, and you'd require a lot of patience and conviction in the companies you're invested in to hold their shares through market turbulence. If you have $5,000 on you right now, here are two such incredible growth stocks to buy.

  • No Government Money, No Problem for Moderna and Pfizer

    Congressional gridlock on Covid-19 funding might lead to vaccine inequity, but it won’t be a bad thing for the manufacturers, which will charge a higher price in the private market.

  • Russia, rejecting default, tells investors to go to western financial agents

    The White House said on Monday that Russia has defaulted on its international bonds for the first time since the Bolshevik revolution, as sweeping sanctions have effectively cut the country off from the global financial system. Until last week, Russia kept on paying on its Eurobonds in foreign currency as per issue conditions yet its dollar and euro coupon transfers made in May, ahead of a key U.S. waiver allowing for such transactions expired, did not reach investors. "Statements of a default are absolutely unjustified," Kremlin spokesperson Dmitry Peskov told a call with reporters on Monday, pointing to the May forex coupon payment.

  • 3M earplug cases pile up; court orders settlement talks

    The manufacturer paid millions just for legal fees in the first three months of 2022 as it contests claims that a type of military earplug were defective. With hundreds of thousands of cases pending, a court ordered mediation starting next month.

  • Will Nvidia Be a Trillion-Dollar Stock by 2025?

    The inventor of the GPU is currently valued at close to $400 billion. Let's see if that can more than double by 2025.